Lung development and repair of hyperoxic injury require closely regulated growth and regeneration of alveolar capillaries. Vascular endothelial growth factor (VEGF), a mitogen for endothelial cells, is expressed by alveolar epithelial cells. Alternative splicing of VEGF mRNA results in isoforms of varying mitogenicity and solubility. We examined changes in the proportions of the VEGF splice variant mRNAs in rabbit lung development and in control, oxygen-injured, and recovering newborn and adult rabbit lungs. The proportion of the 189-amino acid VEGF mRNA, which codes for an isoform that binds to the extracellular matrix, increased fivefold during development (from 8% of total VEGF message at 22 days gestation to 40% in 10-day newborn lungs; P < 0.001). During neonatal oxygen injury, its expression declined from 38 to 8% of VEGF message (P < 0.002) and returned to the control value in recovery. A similar pattern was observed in adults. VEGF protein in lung lavage fluid increased slightly during hyperoxia, declined to barely detectable levels at the 50% lethal dose time point, and increased 10-fold (newborn) or up to 40-fold (adult) in recovering animals. We conclude that alternative splicing may have important roles in the regulation of VEGF activity in developing and injured lungs.

vascular endothelial growth factor; messenger ribonucleic acid; angiogenesis; alveolar type II cells; oxygen; growth factors

This article has been cited by other articles:

				M. Yee, P. F. Vitiello, J. M. Roper, R. J. Staversky, T. W. Wright, S. A. McGrath-Morrow, W. M. Maniscalco, J. N. Finkelstein, and M. A. O'Reilly Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1101 - L1111. [Abstract] [Full Text] [PDF]

				T. C. Carpenter, S. Schomberg, and K. R. Stenmark Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L1075 - L1082. [Abstract] [Full Text] [PDF]

				C. J. Favre, M. Mancuso, K. Maas, J. W. McLean, P. Baluk, and D. M. McDonald Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1917 - H1938. [Abstract] [Full Text] [PDF]

				G. E. Hosford and D. M. Olson Effects of hyperoxia on VEGF, its receptors, and HIF-2{alpha} in the newborn rat lung Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L161 - L168. [Abstract] [Full Text] [PDF]

				C. Mallet, O. Feraud, G. Ouengue-Mbele, I. Gaillard, N. Sappay, D. Vittet, and I. Vilgrain Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E156 - E167. [Abstract] [Full Text] [PDF]

				C. Galambos, Y.-S. Ng, A. Ali, A. Noguchi, S. Lovejoy, P. A. D'Amore, and D. E. deMello Defective Pulmonary Development in the Absence of Heparin-Binding Vascular Endothelial Growth Factor Isoforms Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 194 - 203. [Abstract] [Full Text] [PDF]

				N. K. Ozaki, K. D. Beharry, K. C. Nishihara, Y. Akmal, J. G. Ang, R. Sheikh, and H. D. Modanlou Regulation of Retinal Vascular Endothelial Growth Factor and Receptors in Rabbits Exposed to Hyperoxia Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1546 - 1557. [Abstract] [Full Text] [PDF]

				J. Bhattacharya Gene Therapy for Pulmonary Edema Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 640 - 641. [Full Text]

				W. M. Maniscalco, R. H. Watkins, G. S. Pryhuber, A. Bhatt, C. Shea, and H. Huyck Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L811 - L823. [Abstract] [Full Text] [PDF]